Cargando…
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
IMPORTANCE: Prior authorization requirements may be a barrier to accessing medications for opioid use disorder treatment and may, therefore, be associated with poor health care outcomes. OBJECTIVE: To determine the association of prior authorization with use of buprenorphine-naloxone and health care...
Autores principales: | Mark, Tami L., Parish, William J., Zarkin, Gary A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171554/ https://www.ncbi.nlm.nih.gov/pubmed/32310285 http://dx.doi.org/10.1001/jamanetworkopen.2020.3132 |
Ejemplares similares
-
Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
por: Rao, Tanvi, et al.
Publicado: (2020) -
Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021
por: Nguyen, Thuy D., et al.
Publicado: (2022) -
Association Between Medicare Policy Reforms and Changes in Hospitalized Medicare Beneficiaries' Severity of Illness
por: Sukul, Devraj, et al.
Publicado: (2019) -
Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018) -
Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)